A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer (FAST-GO)
Jonsson Comprehensive Cancer Center
Summary
This study evaluates how the treatment for gastroesophageal cancer affects physical function in patients who receive chemotherapy as part of their treatment for gastroesophageal cancer.
Description
PRIMARY OBJECTIVE: I. To determine the change in physical function from baseline to 6 months of treatment, as measured by the short physical performance battery (SPPB). OUTLINE: This is an observational study. Patients undergo blood sample collection as well as complete surveys, physical function tests and may complete an interview on study.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * \* Adults ≥ 18 years old at the start of study treatment. * New diagnosis of early-stage (Stage I, II, III) esophageal, gastroesophageal junction, or gastric adenocarcinoma, squamous cell carcinoma, or poorly differentiated carcinoma. * Plan to start systemic therapy for resectable or potentially resectable disease. * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * \* Patients with stage I disease with plans to undergo endoscopic resection or surgery alone without perioperative systemic therapy. * M…
Interventions
- OtherNon-Interventional Study
Non-interventional study
Location
- UCLA / Jonsson Comprehensive Cancer CenterLos Angeles, California